Docetaxel Weekly with Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 2296-5262|30|8-9|407-408

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.30, Iss.8-9, 2007-09, pp. : 407-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Improvement of Safety Profile of Docetaxel by Weekly Administration in Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 30, Iss. 8-9, 2007-09 ,pp. : 436-441

Karger

Access to resources Recommend Favorite

Weekly Vinorelbine versus Docetaxel for Metastatic Breast Cancer after Failing Anthracycline Treatment

By  

Oncology Research and Treatment, Vol. 31, Iss. 8-9, 2008-08 ,pp. : 447-453

Karger

Access to resources Recommend Favorite

Weekly Combination of Docetaxel and Vinorelbine in Metastatic Breast Cancer: A Phase I/II Study

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 257-261

Karger

Access to resources Recommend Favorite

Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 438-445

Karger

Access to resources Recommend Favorite

High Efficacy and Low Toxicity of Weekly Docetaxel Given as First-Line Treatment for Metastatic Breast Cancer

By  

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 71-78

Karger

Access to resources Recommend Favorite